GSK Scripted Response For Wellbutrin Probe, Atty Says

Law360, New York (May 3, 2011, 8:59 PM EDT) -- GlaxoSmithKline PLC's in-house legal team planned to "script" a response to regulators if quizzed about nondisclosed information in a probe of the drugmaker's marketing of antidepressant Wellbutrin, a GSK attorney told a Washington jury Tuesday in a former colleague's trial.

Former GSK associate general counsel Lauren Stevens is accused of interfering with a U.S. Food and Drug Administration inquiry of GSK’s Wellbutrin promotion. She is charged with one count of obstructing an official proceeding, one count of falsifying documents before a federal agency and four counts...
To view the full article, register now.

Related

Sections

Case Information

Case Title

USA v. Stevens


Case Number

8:10-cr-00694

Court

Maryland

Nature of Suit

Date Filed

November 8, 2010

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.